Dentsply Sirona Inc   (XRAY)
Other Ticker:  

  Dentsply Sirona Inc Outlook

On February 29 2024 the Dentsply Sirona Inc provided following guidance

During the fourth quarter and full year of 2023, Dentsply Sirona Inc. reported strong financial results. The company provided an outlook for the full year 2024 and increased its dividend.

In a press release published on February 29, 2024, Dentsply Sirona Inc. disclosed that they had experienced positive financial performance in the fourth quarter and throughout the entirety of 2023. The company, listed on the Nasdaq under the symbol XRAY, highlighted their achievements in their most recent financial report.

Looking forward to the full year of 2024, Dentsply Sirona Inc. provided estimates and expectations for their financial performance. The company is optimistic about their prospects for the upcoming year and is confident in their ability to continue delivering value to their shareholders.

Furthermore, Dentsply Sirona Inc. announced that they have raised their dividend, which reflects their strong financial standing and commitment to returning value to their investors. This increase in dividend demonstrates the company's confidence in their future growth and sustainability.

Overall, Dentsply Sirona Inc. is pleased with their financial results for 2023 and is looking forward to a successful year in 2024. Their positive outlook and increased dividend are indicative of their strong performance and dedication to creating value for their stakeholders.

On January 9 2024 the Dentsply Sirona Inc provided following guidance

Dentsply Sirona Inc. announced on January 9, 2024, that it will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The presentation will take place at 7:30 am PT (10:30 am ET). In addition to this, the company provided an update on its anticipated financial results for the full year of 2023.

Dentsply Sirona expects its net sales for 2023 to be at or above the high end of the previously provided outlook range of $3.90 billion to $3.94 billion. The company predicts year-over-year net sales growth in the Essential Dental Solutions, Wellspect Healthcare, and Orthodontic and Implant Solutions segments for the full year and fourth quarter of 2023. However, it also foresees declines in the Connected Technology Solutions segment.

The company has reaffirmed its adjusted earnings per share (EPS) outlook range of $1.80 to $1.85 for the full year of 2023. It also anticipates double-digit adjusted EPS growth in 2024. Dentsply Sirona does not provide forward-looking or preliminary estimates of adjusted EPS on a GAAP basis due to the unavailability of certain information needed for the calculation.

For further details on the adjustments made to calculate adjusted EPS, refer to Exhibit 99.1 of the company's Current Report on Form 8-K, filed on November 2, 2023.

 XRAY $32.0200 $-0.3700 -1.14%

 Volume (M): 2,127   Open : 32.68    52 Wk Avg :  35.70


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com